9,102
Total Claims
$939K
Drug Cost
780
Beneficiaries
$1,204
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-88%
Opioid rate vs peers
0.3% vs 2.2% avg
-15%
Cost per patient vs peers
$1,204 vs $1,411 avg
+14%
Brand preference vs peers
12.1% vs 10.6% avg
Opioid Prescribing
0.3%
Opioid Rate
25
Opioid Claims
$243
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
88% generic
Brand: 1,085 claims · $750K
Generic: 7,904 claims · $183K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 89 | $105K |
| Insulin Glargine,hum.Rec.Anlog | 92 | $83K |
| Semaglutide | 49 | $78K |
| Empagliflozin | 57 | $71K |
| Sitagliptin Phosphate | 34 | $47K |
| Fluticasone/Umeclidin/Vilanter | 48 | $44K |
| Rivaroxaban | 38 | $39K |
| Tiotropium Bromide | 31 | $34K |
| Semaglutide | 11 | $28K |
| Dulaglutide | 11 | $28K |
| Budesonide/Formoterol Fumarate | 39 | $24K |
| Insulin Lispro | 11 | $14K |
| Atorvastatin Calcium | 672 | $12K |
| Insulin Glargine,hum.Rec.Anlog | 23 | $12K |
| Insulin Glargine,hum.Rec.Anlog | 13 | $10K |
Prescribing Profile
Patient Profile
74
Avg Age
65%
Female
1.27
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data